Browsing by Author Hooper, Michael

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 9 of 9
Issue DateTitleAuthor(s)Citation
2005Effect of orlistat on cardiovascular disease risk in obese adults.Caterson, Ian; Hooper, Michael; Sullivan, David; Carey, D; Hills, A P; Marks, S; Proietto, J; Strauss, B J; Swinburn, Boyd A; Welborn, Timothy A.; Molecular & Microbial Bioscien; Concord Clinical School: Medicine; Molecular & Microbial BioscienEffect of orlistat on cardiovascular disease risk in obese adults., Diabetes, Obesity & Metabolism, vol.7,(3),2005,pp 254-62
2011Genome-wide association identifies three new susceptibility loci for Paget's disease of boneHooper, Michael; Albagha, Omar M E; Alonso, Nerea; Brandi, Maria Luisa; Chung, Pui Yan Jenny; Cundy, Tim; Dargie, Rosemary; Devogelaer, Jean-Pierre; et al, various; Goodman, Kirsteen; Visconti, Micaela R; Wani, Sachin; Concord Clinical School: MedicineGenome-wide association identifies three new susceptibility loci for Paget's disease of bone, Nature Genetics, vol.43, 7, 2011,pp 685-689
2010Genome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of boneHooper, Michael; Albagha, Omar M E; Alonso, Nerea; Cundy, Tim; Dargie, Rosemary; del Pino Montes, Javier; di Stefano, Marco; Dunlop, Malcolm G; Fraser, William D; Gonzalez-Sarmiento, Rogelio; Isaia, Gianluca; Langston, Anne L; Nicholson, Geoff C; Ralston, Stuart H; Tenesa, Albert; Visconti, Micaela R; Walsh, John P; Concord Clinical School: MedicineGenome-wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone, Nature Genetics, vol.42, 6,pp 520-524
2009Hypovitaminosis D in Chinese type 2 diabetes: lack of impact on clinical metabolic status and biomarkers of cellular inflammation.Brown, Michael; Hooper, Michael; Molyneaux, Lynda; Wong, Jencia; Yue, Dennis; Luo, C; Medical Radiation Sciences; Concord Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineHypovitaminosis D in Chinese type 2 diabetes: lack of impact on clinical metabolic status and biomarkers of cellular inflammation., Diabetes and Vascular Disease Research, vol.6, 3,pp 194-199
2007Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronateHooper, Michael; Brown, Jacques P; Curiel, Manuel Diaz; Devogelaer, Jean-Pierre; et, al; Fraser, William D; Hosking, David; Lyles, Kenneth; Miller, Paul; Su, Guoqin; Zelenakas, Ken; Concord Clinical School: MedicineLong-term control of bone turnover in Paget's disease with zoledronic acid and risedronate, JOURNAL OF BONE AND MINERAL RESEARCH 2005, vol.22,(1),2007,pp 142-148
2009Randomized, active-controlled study of once-weekly alendronate 280 mg high dose oral buffered solution for treatment of Paget's diseaseHooper, Michael; Faustino, A; Gilchrist, N; Hosking, David; Leung, A; Reid, I; Salzmann, G; Selby, P; West, J; Wu, Min; Concord Clinical School: MedicineRandomized, active-controlled study of once-weekly alendronate 280 mg high dose oral buffered solution for treatment of Paget's disease, Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol.20,(1),2009,pp 141-150
2005Risedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial.Hooper, Michael; D'Emden, Michael C.; Ebeling, Peter R; Ernst, T. F.; Graham, J. J.; Nicholson, Geoff C; Roberts, A. P.; Wenderoth, D; Concord Clinical School: MedicineRisedronate prevents bone loss in early postmenopausal women: a prospective randomized, placebo-controlled trial., Climacteric, vol.8,(3),2005,pp 251-262
2008Treatment of Paget's disease of bone: a survey of clinical practice in AustraliaHooper, Michael; Attewell, R; Eisman, John A.; Ferrari, G; Fletcher, S; Stuckey, B G A; Walsh, John P; Wark, John D.; Concord Clinical School: MedicineTreatment of Paget's disease of bone: a survey of clinical practice in Australia, Bone, vol.42,(6),2008,pp 1219-1225
2005Ubiquitin-Associated Domain Mutations of SQSTM1 in Paget’s Disease of Bone: Evidence for a Founder Effect in Patients of British DescentHooper, Michael; Meier, Christian; Cundy, Tim; Daroszewska, Anna; Fraser, William D; Hocking, Lynne J; Lucas, Gavin JA; Nicholson, Geoff C; Ralston, Stuart H; Walsh, John P; Concord Clinical School: Medicine; MedicineUbiquitin-Associated Domain Mutations of SQSTM1 in Paget’s Disease of Bone: Evidence for a Founder Effect in Patients of British Descent, JOURNAL OF BONE AND MINERAL RESEARCH 2005, vol.20,(2),2005,pp 227-231